HOME >> MEDICINE >> NEWS
Seminar examines biology of pain and nerve repair in peripheral nerve disease

The Jack Miller Center for Peripheral Neuropathy at the University of Chicago will present its second biennial scientific symposium on the "Frontiers of Peripheral Nerve Research," from 9 A.M. to 4:30 P.M. on Friday, April 28, 2006, at the University of Chicago's Ida Noyes Hall, 1212 E. 59th Street, Chicago.

The seminar will focus on pain mechanisms and peripheral nerve development, repair and regeneration. Speakers include Rhona Mirsky of University College, London; Elior Peles of the Weizmann Institute, Israel; Jeff Milbrandt of Washington University in St. Louis; Stephen Waxman of Yale; Bill Snider of the University of North Carolina; and Clifford Woolf of Harvard.

Peripheral neuropathy is a common disorder, affecting about three percent of all those over age 60. The disease results from damage to the nerves and nerve processes that are located outside the brain and spinal cord. It has many causes, including diabetes, traumatic injury to the nerves, damage to or swelling of the sheaths around nerves, circulation problems, genetics, or a misdirected immune attack on nerve tissue. Symptoms include pain in the hands and arms, legs and feet--sometimes constant and quite severe--as well as progressive numbness and weakness in the arms and legs.

The Miller Center promotes multidisciplinary investigations into peripheral neuropathies, focusing on efforts to determine the cause, at the molecular level, and finding ways to use that knowledge to produce a cure for these disorders. The Center was founded in 1999 by a generous gift from Jack Miller of Lincolnshire, Illinois, founder and president of Quill Corporation. Miller, who suffers from peripheral neuropathy, was frustrated by the lack of information about the disease and decided to launch a concerted effort by neuroscientists at the University of Chicago to investigate the basic biology of the neuropathy and to search for better treatments and, eventually, a cure for this common nerve di
'"/>

Contact: John Easton
john.easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
27-Feb-2006


Page: 1 2 3

Related medicine news :

1. NCI/NIH Pain Consortium Science Writers Seminar
2. NCI/Fox Chase Cancer Center Science Writers Seminar
3. New study examines effectiveness of tailored health messages
4. Study examines characteristics of female high school students who report steroid use
5. Study examines genetic factors associated with head and neck cancer
6. Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors
7. MGH study examines impact of infection with both HIV and hepatitis C virus
8. Columbia study examines ADHDs role in smoking
9. Quality care assessment examines surgical quality for colorectal cancer patients
10. Study examines usefulness of cardiac CT scan for detecting blockages in coronary arteries
11. Study examines link between racial discrimination and mental and physical health

Post Your Comments:
(Date:6/19/2013)... 19, 2013 Amber Roberson with ... Benefits, LLC, Native Care Health, LLC and Medcase, ... Health Underwriters’ (NAHU) new professional development course on ... This continuing education course for agents has been ... receive eleven education credits from the Missouri Department ...
(Date:6/19/2013)... The Journal of Parasitology – Although ... software, it creates questions of ethics. For scientific publications, ... already published case shows, scientific publications need clear guidelines ... Journal of Parasitology features a commentary on ... article published in the Journal of the New York ...
(Date:6/19/2013)... study published in the June 19 online edition of ... by researchers from the University of California, San Diego ... that take place when cardiac regeneration occurs in zebrafish ... that various cell lines in the heart are more ... than previously thought. , More importantly, the research reveals ...
(Date:6/19/2013)... reveals significant disparities between minority and white clients ... programs. Moreover, these disparities vary widely from state ... for most states there,s something amiss," says Stephan ... "There are strong racial and ethnic disparities for ... treatment programs successfully, and those disparities are something ...
(Date:6/19/2013)... -- Nearly 70 percent of Americans are ... than half take two, Mayo Clinic researchers say. ... prescribed, their study found. Twenty percent of patients ... to the findings, published online in the journal ... For audio and video of Dr. Jennifer St. ...
Breaking Medicine News(10 mins):Health News:RWI Benefits, LLC Becomes PPACA Certified 2Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... --  Nektar Therapeutics (Nasdaq: NKTR ) today ... study for NKTR-181, a first-in-class, opioid analgesic molecule ... slow rate of entry is designed to reduce the euphoria ... current opioid analgesics. 1 In the study data being ... in "drug liking" and "feeling high" scores and had highly ...
(Date:6/19/2013)... June 19, 2013 BD Biosciences, a segment of ... a leading global medical technology company, today announced the launch ... latest in its line of high-performance research flow cytometers. ... multicolor analysis with the most compact footprint in its class ... a height of 30" (76.2 cm). Recognizing that space is ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
Cached News: